Does USTEKINUMAB Cause Hypercholesterolaemia? 1,010 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,010 reports of Hypercholesterolaemia have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 1.2% of all adverse event reports for USTEKINUMAB.
1,010
Reports of Hypercholesterolaemia with USTEKINUMAB
1.2%
of all USTEKINUMAB reports
980
Deaths
737
Hospitalizations
How Dangerous Is Hypercholesterolaemia From USTEKINUMAB?
Of the 1,010 reports, 980 (97.0%) resulted in death, 737 (73.0%) required hospitalization, and 786 (77.8%) were considered life-threatening.
Is Hypercholesterolaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 1,010 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Hypercholesterolaemia?
ALENDRONATE (1,607)
METHOTREXATE (1,547)
TOCILIZUMAB (1,483)
ADALIMUMAB (1,479)
ABATACEPT (1,410)
RITUXIMAB (1,389)
PREDNISONE (1,377)
INFLIXIMAB (1,338)
DICLOFENAC (1,331)
LEFLUNOMIDE (1,322)
Which USTEKINUMAB Alternatives Have Lower Hypercholesterolaemia Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE